
Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy
Author(s) -
Sungjin Kim,
Timothy P. DiPeri,
Michelle Guan,
Veronica Placencio-Hickok,
Haesoo Kim,
Jar-Yee Liu,
Andrew Eugene Hendifar,
Samuel J. Klempner,
Ryan David Nipp,
Alexandra Gangi,
Miguel Burch,
Kevin M. Waters,
May Cho,
Joseph Chao,
Katelyn M. Atkins,
Mitchell Kamrava,
Richard Tuli,
Jun Gong
Publication year - 2020
Publication title -
world journal of gastrointestinal surgery
Language(s) - English
Resource type - Journals
ISSN - 1948-9366
DOI - 10.4240/wjgs.v12.i9.377
Subject(s) - medicine , palliative chemotherapy , chemotherapy , surgery , esophageal cancer , palliative treatment , palliative care , cancer , oncology , nursing
Palliative therapy has been associated with improved overall survival (OS) in several tumor types. Not all patients with metastatic esophageal cancer receive palliative chemotherapy, and the roles of other palliative therapies in these patients are limited.